EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark EMENDOBIO was filed as Word mark on 12/09/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/19/2022.
The current status of the mark is "Registration cancellation pending".
| Trademark form | Word mark |
| File reference | 018618074 |
| Application date | December 9, 2021 |
| Publication date | January 10, 2022 |
| Entry date | April 19, 2022 |
| Expiration date | December 9, 2031 |
Trademark owner
400 West 61st Street, 4th Floor
10069 New York
US
10069 New York
US
Trademark representatives
Silkeborgvej 2
8000 Aarhus C
DK
goods and services
1
Enzymes for scientific and research purposes; nucleases and nuclease panels for scientific and research purposes; nucleases and nuclease panels derived from biotechnological processes for use in scientific and research purposes; assays and reagents for use in genetic research; nucleases and nuclease panels for use in genetic research
5
Enzyme preparations for medical purposes; enzymes for medical purposes; nucleases and nuclease panels for medical purposes; reagents for use in medical genetic testing; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the prevention of diseases or decisions caused by genetic predispositions; pharmaceutical preparations for editing of faulty genes; chemical preparations for pharmaceutical or medical purposes, namely, for editing of faulty genes; anti-cancer preparations; pharmaceutical products for the prevention and treatment of cancer; ocular pharmaceuticals; pharmaceutical preparations and substances for the treatment of genetic blood disorders
42
Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, selection, optimization or development of nucleases for gene targeting, gene editing, or gene therapy; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; scientific research in the field of genetics, gene editing and genetic engineering; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; providing medical and scientific research information in the fields of pharmaceuticals and genetics; scientific research consulting in the field of genetics; scientific research consulting in the field of gene editing; scientific research consulting in the field of selection and optimization of nucleases for gene editing and pharmaceutical development; scientific research in the field of selection and optimization of nucleases for gene editing and pharmaceutical development; pharmaceutical research services; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; technical research in the field of pharmaceutical studies; technical consulting in the field of pharmaceutical studies; research and development in the pharmaceutical and biotechnology fields; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; testing of pharmaceuticals; research on the subject of pharmaceuticals; laboratory research services relating to pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research in the field of pharmaceuticals; medical research services in the field of cancer; medical research services in the field of genetic blood disorders; medical research services in the field of genetic ocular disorders; medical and scientific research in the field of cancer treatment and diagnosis; scientific research for medical purposes in the field of gene editing and genetic disorders; scientific research for medical purposes in the field of nuclease and nuclease panel discovery and optimization for the development of gene-targeting pharmaceuticals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 15, 2022 | appealed, Published |
ID: 11018618074